Emergent BioSolutions to Participate in Investor Conferences
May 05 2021 - 4:05PM
Emergent BioSolutions Inc. (NYSE: EBS) announced today that members
of the company’s senior management team will participate in the
following investor conferences:
- Goldman Sachs Credit and Leveraged Finance
ConferenceMay 17, 20211-on-1 meetings only
- Benchmark Company Healthcare House Call
ConferenceMay 26, 20211-on-1 meetings only
- Singular Research Spring Select Webcall May
27, 2021Company presentation scheduled at 8:00 am Pacific / 11:00
am Eastern
For conferences where a presentation is planned, the company’s
webcast presentation may include a discussion of the company's
recent business developments as well as its financial results and
guidance. The webcast will be available both live, if possible, and
by replay, and will be accessible from the Emergent website.
About Emergent BioSolutionsEmergent
BioSolutions is a global life sciences company whose mission is to
protect and enhance life. Through our specialty products and
contract development and manufacturing services, we are dedicated
to providing solutions that address public health threats. Through
social responsibility, we aim to build healthier and safer
communities. We aspire to deliver peace of mind to our patients and
customers so they can focus on what’s most important in their
lives. In working together, we envision protecting or enhancing 1
billion lives by 2030. For more information, visit our website and
follow us on LinkedIn, Twitter, and Instagram.
Investor Contact:Robert G. BurrowsVice
President, Investor
Relations240-631-3280burrowsr@ebsi.com
Media Contact:Matt HartwigDirector, Media
Relationshartwigm@ebsi.com
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Sep 2023 to Sep 2024